INSIDE PHARMA

Share this post
Does the pharmaceutical industry turn a blind eye to side effects?
hedleyrees.substack.com

Does the pharmaceutical industry turn a blind eye to side effects?

Hint: Yes.

Hedley Rees
May 16
10
4
Share this post
Does the pharmaceutical industry turn a blind eye to side effects?
hedleyrees.substack.com

Another extract from Find It, File It, Flog It: Pharma's Crippling Addiction and How to Cure it, by Hedley Rees.

“Does the industry turn a blind eye to side effects?

An article in the UK Telegraph by Laura Donnelly and Edward Malnick, titled Doctors refusing to prescribe statins, reported on the United Kingdom’s National Health Service’s advice that there should be widespread use of statins:

The advice has divided experts, with prominent doctors accusing NICE’s (National Institute for Health and Care Excellence) experts of being too close to the Pharmaceutical industry.

Debate has raged for some time over the risks and benefits of taking a statin every day. The proponents of statins argue that lower cholesterol levels serve to reduce the overall risk of heart problems in the over 55’s population, whereas the opponents do not accept patients should be exposed to the potential side effects unless there is a properly diagnosed need.

One general practitioner describes the side effects as “horrific,” and a large percentage refuse to follow the advice, even though they could be financially penalized by not following NICE’s dictate.

Aside from the statin debate, the industry has a less-than-stellar record for being truthful about safety profiles of drugs, as evidenced by Vioxx, which has left a bitter taste in the mouths of many families and doctors affected.

For those not familiar with the story, Merck gained US FDA approval to launch a painkiller Vioxx (rofecoxib), in 1999, based upon clinical trial evidence.

Following launch, there emerged a growing body of evidence that the drug was implicated in heart attacks and death. The Drugwatch site reported “In the years that followed, it was mired in scandal. Merck was accused of misleading doctors and patients about the drug’s safety, fabricating study results to suit the company’s needs, continually thwarting an FDA scientist from revealing the drug’s problems and skirting federal drug regulations.”

During this time, patients were dying.

Campaigns have been started to achieve far greater visibility of safety profiles and other critical issues involved in clinical trials. None of this, however, seems to be persuading the industry to change.”

If you would like to here more on this, and a ton of other important stuff on the broken pharmaceutical system, and how to put it right, why not check out:

Find It, File It, Flog It: Pharma's Crippling Addiction and How to Cure it, by Hedley Rees?

That’s it for now,

Hedley :O)

Thanks for reading Inside Pharma! Subscribe for free to receive new posts and support my work.

4
Share this post
Does the pharmaceutical industry turn a blind eye to side effects?
hedleyrees.substack.com
4 Comments

Create your profile

0 subscriptions will be displayed on your profile (edit)

Skip for now

Only paid subscribers can comment on this post

Already a paid subscriber? Sign in

Check your email

For your security, we need to re-authenticate you.

Click the link we sent to , or click here to sign in.

DoorlessCarp🐭
Writes DoorlessCarp’s Scientific Liter… May 16Liked by Hedley Rees

Oh yes, high or infinite NNT, are they still pushing these?

Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms

https://doorlesscarp953.substack.com/p/statins-stimulate-atherosclerosis?s=w

Expand full comment
ReplyCollapse
1 reply by Hedley Rees
Jason Morphett PhD
Writes COVID Adverse Events Insight May 16

It always amazes me how quickly pharma (via the doctor) is ready to open the dispensary and dole out the drugs when the conversation should be along the lines of 'tell me what you're eating and what exercise you do?'

Expand full comment
ReplyCollapse
2 more comments…
TopNewCommunity

No posts

Ready for more?

© 2022 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing